Mesp1 and Mesp2 encode bHLH-type transcription factors, Mesp1 and Mesp2, respectively. The expression of both genes is observed in the nascent mesoderm, and subsequently in the rostral presomitic mesoderm. To determine the regulatory mechanism for gene expression, we attempted to identify enhancer elements by transient transgenic analysis. At least two enhancers, which are responsible for the expression of the two genes in the early mesoderm (early mesodermal enhancer, EME) and the presomitic mesoderm (PSM enhancer, PSME), and one suppressor, which is responsible for the rostrally restricted expression in the presomitic mesoderm, were identified. Deletion studies of these enhancer elements indicate that either gene may use the same enhancer for early mesoderm development, whereas both genes may utilize separate enhancers to regulate their expression in the presomitic mesoderm. q
Introduction
Eukaryotic gene expression is mediated by compact cisregulatory modules or enhancers, which are bound by specific sets of transcription factors (Arnone and Davidson, 1997) . The combinatorial interaction of these bound transcription factors determines time-and tissue-specific gene activation or repression. Structurally related genes, which are called family genes, are often located close to each other in the same chromosome and share similar expression patterns and functions, as exemplified by Hox gene clusters (Kmita et al., 2000) . The proximity of these genes may have emerged from gene duplication during evolution; therefore, it is important to analyze the expression and regulatory mechanisms of such family genes from this point of view.
Mesp1 and Mesp2, which encode bHLH-type transcription factors, Mesp1 and Mesp2, respectively, are both located on chromosome 7 (Saga et al., 1997) . They share almost identical bHLH motifs but their amino acid compositions outside these motifs are different. Mesp1 is expressed in the early mesoderm that is destined to become the extraembryonic and cranial-cardiac mesoderm. However, its expression is downregulated rapidly and a second expression domain appears as a pair of bands in the presomitic mesoderm (Saga et al., 1996) . An almost similar expression profile was obtained for Mesp2. However, the expression level of Mesp2 in the nascent mesoderm is much lower than that of Mesp1. In our previous studies, we generated Mesp1-and Mesp2-single-knockout mice to determine the function of the two genes. Disruption of Mesp1 resulted in a morphogenetic abnormality of the heart, cardia bifida (Saga, 1998; Saga et al., 1999) , although relatively normal somites were generated. Analyses of Mesp2-single-knockout mice revealed the critical requirement of Mesp2 for the normal segmentation of somites, the generation of the rostral identity of sclerotomes and the maintenance of the rostro-caudal polarity of somites (Saga et al., 1997) . However, no notable defect was observed prior to somitogenesis in Mesp2-deficient mice, which was consistent with the low expression level of Mesp2 during the early stage of gastrulation. On the other hand, analyses of Mesp1-null embryos revealed that the delayed migratory activity of mesodermal cells appeared to be rescued by the prolonged expression of Mesp2. This is further supported by the analysis of Mesp1, Mesp2-double-knockout mice that show complete lack of mesodermal migration. Therefore, these genes are coexpressed during gastrulation and their transcription is coordinately regulated. The function of Mesp1 during somitogenesis was not clearly revealed because of the early death of the double-knockout mice. However, the Mesp1 cDNA knocked in the Mesp2 locus could rescue the defects caused by Mesp2 deficiency in a dosage-dependent manner (Saga, 1998) . Therefore, these two genes are functionally redundant. This study is conducted to elucidate whether these two functionally and transcriptionally redundant genes utilize the same enhancer element for their expression. We used transient transgenic analysis to determine the two distinct enhancers responsible for early and presomitic mesoderm development. Furthermore, a suppressor responsible for the rostrally restricted expression of Mesp2 in the presomitic mesoderm is identified.
Results

Transient transgenic analysis revealed two enhancers specific to nascent mesoderm and presomitic mesoderm
To define the enhancer element responsible for Mesp1 or Mesp2 transcription, we first analyzed the DNA fragment upstream of the translation initiation site in both Mesp1 and Mesp2 with endogenous promoters. Transcription initiation sites for both genes are mapped upstream of the ATG site (272 bp for Mesp1 and 225 bp for Mesp2, respectively). For Mesp1, a 5.6 kb fragment upstream of the ATG translation initiation site was linked to LacZ, yielding the P1L construct (Fig. 1A) . For Mesp2, a 7.3 kb fragment upstream of the ATG translation initiation site was fused to LacZ, yielding the P2L construct (Fig. 1A) . These constructs were injected separately into the pronuclei of fertilized embryos. Embryos injected with P1L constructs were allowed to develop in utero until 7.5 days post coitum (dpc) to analyze the enhancer activity for the early mesoderm (hereafter referred to as EME), and those injected with P2L constructs were allowed to develop until 9.5 dpc to analyze the enhancer activity for the presomitic mesoderm (hereafter referred to as PSME). Results of initial trials revealed that embryos injected with P1L constructs exhibited the enhancer activity for the early nascent mesoderm (Fig. 1B) , while embryos injected with P2L constructs exhibited the enhancer activity for the presomitic mesoderm (Fig. 1F) . b-galactosidase (b-gal) activity driven by EME is restricted in the mesoderm derived from a primitive streak (see Fig. 3C ); this activity is strong in the posterior region and weak in the anterior region, in agreement with endogenous Mesp1 expression (Saga et al., 1996) . On the other hand, due to its stability, b-gal activity driven by PSME has been observed in several segmented somites, regardless of whether RNA transcription is restricted in the presomitic mesoderm immediately before segmentation (Takahashi et al., 2000) . The specificity of the staining patterns was confirmed by analysis of both Mesp1 and Mesp2 expressions in LacZ-knockin mice (Saga et al., 1999; Takahashi et al., 2000) . To locate cis-elements responsible for the expression, we performed deletion analyses of both constructs. Table 1 summarizes the results of these transient transgenic assays.
For the EME, an initial deletion from the 5 0 upstream region of the P1L revealed that the enhancer was located between the NcoI and BglII sites (1.3 kb) at approximately 4 kb upstream of the Mesp1 translation initiation site (Fig.  1C) . To define the minimum enhancer elements, several DNA fragments were ligated to the P1L-B2 construct and analyzed by transient transgenic assay. The P1L-NB3 construct showed relatively strong specific activity (Fig.  1D) ; however, further deletion did not provide clear results.
Only one out of four PCR positive P1L-NB6 transgenic embryos showed weak b-gal activity ( Table 1 ), indicating that multiple cis-elements might be required to achieve full enhancer activity (Fig. 1E ). The P1L-X1 construct did not exhibit any b-gal activity although it contained the entire putative enhancer region, indicating that the promoter sequence was located upstream of the XbaI site (2110 bp from the ATG site).
For the PSME, a sequential deletion from the 5 0 upstream region of the P2L revealed that the enhancer was located very close to the ATG translation initiation site (Fig. 1A) . Deletion of up to 2185 bp from the ATG site resulted in a strong enhancer activity without any ectopic expression of b-gal ( Fig. 1G-I ). Further deletion was conducted to map the minimum core enhancer element for the presomitic mesoderm. By sequence comparison with putative zebrafish Mesp2 homologue mespb (Sawada et al., 2000) , several conserved sequences were revealed downstream of 2185 bp ( Fig. 2A) . We generated several constructs by PCR using the sequences in the upstream region as the 5 0 primer (as indicated in Fig. 2A ) and the LacZ sequence as the 3 0 primer. Deletion of up to 2160 bp did not eliminate the expression of b-gal in somites (Fig. 2B) ; however, six out of 12 LacZ-positive embryos exhibited ectopic expression in the tailbud region. Deletion of up to 2135 bp almost eliminated the expression in somites, and only one embryo out of 11 PCR-positive embryos exhibited some expression in the tailbud region (Table 1) . Similarly, weak expression was observed in one out of 14 PCR-positive embryos with the P2L-100 construct (Table 1) . These results indicate that the enhancer is located between 2160 and 2135 bp positions. Therefore, the core enhancer sequence is possibly TTTCCCAG, which is shared by Mesp2 and mespb. To confirm this possibility, we conducted further deletion to generate P2L-153, P2L-148 and P2L-143. As shown in Fig. 2C ,D, the expression of b-gal in the somitic region is . The level of expression was reduced as the fragment was shortened (C,D) and only weak expression was observed for the shortest fragment P1L-NB6 (E). In contrast, strong PSME activity was retained in the 185-bp upstream sequence of Mesp2 (I).
reproduced by P2L-153 but not by P2L-148, which strongly indicates that the TTTCCCAG sequence is important for the activation of Mesp2 in the somitic mesoderm. However, it is noted that the expression in the embryos containing the P2L-153 transgene shows the expression in the tailbud region, which is never observed in the transgenic lines containing a longer 5 0 sequence than 2160 bp, indicating that the sequence between 2185 and 2160 bp region may act as a suppressor in the tailbud region. Consistent with this, homologous sequences between mouse and zebrafish are observed around the 2185 bp region. To further confirm that the core sequence TTTCCCAG is a sole enhancer for the activation, we constructed another transgene that contains 1 kb upstream sequence from the ATG without TTTCCCAG sequence. Surprisingly, however, we could obtain completely normal b-gal expression (data not shown), indicating existence of another activator besides TTTCCCAG within the 1 kb upstream region.
EME activity is observed in early nascent mesoderm and shows ectopic activity in muscle lineage of embryos at later stage of development
In order to analyze the activity of EME during development, we generated several transgenic lines. First, three transgenic lines injected with P1L constructs were established (P1L-A, B and C), and the expression patterns were examined between 7.5 and 10.5 dpc. The initial expression in the nascent mesoderm was reproduced in either embryo although the levels of expression were different from each other and lower than that of the endogenous expression (Fig.  3A,B) . Transverse section confirmed that the expression was restricted to the mesodermal cells (Fig. 3C) . However, it was noted that the transgene was activated even in the precursor of the paraxial mesoderm and part of the lateral plate mesoderm (Fig. 3A,B) as revealed by the persistent bgal activity in the somite and lateral plate mesoderm after 8.5 dpc (Fig. 3D ,E,G,H). The initial expression in the cranial and cardiac mesodermal precursors was downregulated as shown in the case of the endogenous one (Fig.  3C,D) . In a much later stage, strong ectopic expression of b-gal was observed in the muscle lineage, which was never observed endogenously (Fig. 3G) . Initially, we interpreted that the expression of b-gal in somites might reflect endogenous Mesp1, because fragment P1L might contain an enhancer for the presomitic mesoderm. However, the expression of transgene in somites was retained longer after segmentation, and b-gal activity was enhanced as cells differentiated to the muscle lineage. Such an expression has never been observed endogenously. However, in situ hybridization using the LacZ probe revealed strong expression of the transgene in the presomitic mesoderm immediately before segmentation, as observed for endogenous Mesp1 and Mesp2 (Fig. 3I-L, arrowheads) . The LacZ expression level decreased once segmented somites were generated, but was reactivated after cell differentiation. Therefore, the transgene might include the enhancer for the presomitic mesoderm in addition to that for the early mesoderm; however, it might lack the element required for the suppression after segmentation. To separate these enhancers, we re-examined the activity of P1L-NB by transient transgenic assay. However, a similar ectopic expression at the later stage of development was observed (data not shown), suggesting that P1L-NB contained enhancers for both early and presomitic mesoderms, and some suppressor elements present outside the P1L region.
2.3. PSME is necessary for activation of transcription but additional element may be required for regulation of expression domain Transgenic lines containing P2L enhancers of different lengths were generated to determine the activity of PSME during development. The generated transgenic lines with P2L constructs reproduced expression patterns in the presomitic mesoderm that were almost similar to those in Mesp2-LacZ-knockin mice (Takahashi et al., 2000) . Rostrally localized LacZ stripes were observed in both the segmented somites and the presomitic mesoderm immediately before segmentation ( Fig. 4A-C) . No expression was observed in the early nascent mesoderm in 6.5-7.5-dpc embryos, indicating that there was no enhancer activity for the early mesoderm in this transgene (data not shown). Transgenic lines generated with short P2L fragments exhibited similar and unique patterns of expression. The P2L-800 construct basically showed an expression pattern similar to that of the P2L construct (data not shown). However, the P2L-185 construct did not show a stripe pattern. The similarity of the expression domains indicated that transcriptional activation occurred at a similar site in the presomitic mesoderm; however, no rostral localization of b-gal activity was observed (Fig. 4C,D) . To compare the expression of the LacZ transcript with that of endogenous Mesp2, we conducted whole-mount in situ hybridization (Fig. 4F-J) .
As expected, embryos of the P2L transgenic line exhibited similarly distinct bands using either the Mesp2 or LacZ probe (Fig. 4F,G) . In contrast, embryos of the P2L-185 transgenic line exhibited diffused expanded bands of the LacZ transcript (Fig. 4I,J) , different from the endogenous Mesp2 band (Fig. 4H ). As we have previously reported (Takahashi et al., 2000) , Mesp2 is expressed initially in both prospective rostral and caudal halves of a somite, but the expression in the caudal half is more rapidly downregulated than that in the prospective rostral one, generating a stripe pattern by b-gal staining. Accordingly, the P2L-185 construct must contain an enhancer essential for the activation of the Mesp2, but may lack the cis-element required for the downregulation of Mesp2 transcription in the caudal compartment (referred as caudal suppressor element, CSE). To further map CSE, we investigated the P2L-300 construct and found that stripe formation was not clearly Fig. 4 . Comparison of enhancer activities between P2L and P2L-185. The P2L enhancer reproduced the endogenous Mesp2 expression pattern, which showed a striped pattern with graded b-gal activity within one somite (A,B), while the P2L-185 enhancer showed a similar but non-striped pattern without graded b-gal activity within the somite (C,D). A sagital section of the P2L embryo stained for b-gal activity showed difference in staining the intensity within a somite (E: rostral region is stronger; indicated by arrowheads). The endogenous pattern of the Mesp2 transcript (F) was reproduced in the expression of the LacZ transcript in the P2L embryo (G); however, the LacZ transcript in the P2L-185 embryo showed a diffuse broad pattern (I,J), which differed from the endogenous pattern of Mesp2 expression (H). p2 (Mesp2) and LacZ were used as RNA probes for in situ hybridization.
reproduced (date not shown), indicating that the cis-element might be located between 2300 and 2800 bp.
Both Mesp1 and Mesp2 genes may share EME
Our previous study has indicated that both Mesp1 and Mesp2 have the same expression pattern in the early nascent mesoderm, but the expression level of Mesp2 is considerably lower than that of Mesp1 .
Because of the similarity in the time and place of expression, we assumed that both genes share the same enhancer element for driving their expression in the nascent mesoderm. To confirm this assumption, we constructed a targeting vector in which EME was deleted together with Mesp1 (DE1). The linearized vector was introduced into TT2 ES cells by electroporation, and G418-resistant cells were screened by PCR (Fig. 5A) . One PCR-positive clone (#62) was subjected to Southern blot analysis to confirm whether it is a correct homologous recombinant (Fig. 5B) . The #62 ES cells were aggregated with eight-cell embryos and chimeric mice were generated. The chimeric mice successfully transferred the DE1 allele to the next generation in order to establish a DE1 mutant mouse line. First, we compared the phenotype of the homozygous embryo with that of the Mesp1-null embryo (Fig. 5C) . In our previous studies, we showed that Mesp1-null embryos exhibited abnormal heart morphogenesis, resulting in cardia bifida (Saga et al., 1999) . The primary cause of this abnormality was the lack of migratory activity of Mesp1-expressing heart precursor cells. However, the defect appeared to be rescued partially by the expression of another gene of the same family, Mesp2, because the lack of these two genes resulted in the complete failure of mesoderm migration . The apparent morphology of the DE1 embryo recovered at 8.5 dpc was not different from that of the Mesp1-null embryo (Fig. 6A) . However, further development of the DE1 embryo was severely affected. No heart or somites were generated and most embryonic tissues were disorganized (Fig. 6B,C) . It has been noted that the overt morphology of the DE1 embryo is similar to that of Mesp1, Mesp2-double-knockout mouse . To analyze whether the severity of this phenotype was due to the lack of Mesp2 expression, we examined the Mesp2 expression in a 7.5-dpc embryo. Previous analyses of the Mesp1-null embryo showed that the Mesp2 expression was maintained in the absence of the Mesp1 protein in the Mesp1-null embryo for a longer time than that in the wildtype embryo, and the prolonged Mesp2 expression was supposed to account for the rescue event in the Mesp1-null embryo . As expected, the level of Mesp2 expression could hardly be detected and was clearly reduced in DE1 embryos (Fig. 6D) . However, a very low level of expression was still observed in the DE1 embryo, indicating the presence of an additional cis-element Fig. 6 . Different uses of Mesp1 and Mesp2 enhancers, EME and PMSM. The DE1 embryo showed phenotype similar to that of the Mesp1-null embryo before 8.5 dpc (A), but the phenotype became much more severe than that of the Mesp1-null embryo after 8.5 dpc (B) and was similar to that of the Mesp1, Mesp2-double-knockout mouse . C shows a high magnification of the DE1 embryo shown in B after removal of the extraembryonic yolk sac. The DE1 embryo at 9.5 dpc has only a headfold (hf) and allantois (al) and no posterior structures. (D) Reduction of Mesp2 expression level in the DE1 embryo compared with that of the wild-type embryo indicates the lack of the Mesp2 enhancer in the DE1 embryo. Mesp1 is strongly expressed in either Mesp2-null (E) or Mesp2-lacZ (F) embryos, indicating different uses of enhancers for Mesp1 expression in the presomitic mesoderm.
that might be involved in the normal expression of Mesp2, although a major enhancer for the initial mesodermal lineage was possibly shared by this gene with Mesp1.
PSME is not the only enhancer for the presomitic mesoderm
Similarly, we compared two knockout mice that differed in the targeting strategy for the Mesp2 locus (Fig. 5C ). Mesp2-null mice lacked the 5 0 upstream 1.6-kb fragment containing both PSME and CSE sequences (Saga et al., 1997) , while Mesp2-LacZ mice, which had no deletion of the 5 0 upstream sequence, retained these enhancer sequences (Takahashi et al., 2000) . These knockout mice showed almost the same phenotype, which was defective somitogenesis leading to the fusion of pedicles in the vertebra. In addition, their levels and patterns of Mesp1 expression were also similar (Fig. 6E,F) , indicating that Mesp1 uses a different enhancer for regulating its own transcription in the presomitic mesoderm.
Discussion
3.1. Both Mesp1 and Mesp2 genes may share the major enhancer for nascent mesoderm and their expression levels are strongly correlated with their phenotypes
Our previous study using a gene knockout strategy revealed a close functional relationship between Mesp1 and Mesp2. Mesp1-knockout mice exhibited heart abnormality due to delayed migration of Mesp1-expressing heart precursor cells (Saga et al., 1999) . However, the defect was partially rescued by Mesp2 because Mesp1, Mesp2 double knockout caused a complete inhibition of mesodermal migration . Furthermore, we found that Mesp2 knocked in the Mesp1 locus completely rescued the defect in the Mesp1-null embryo (unpublished data). Therefore, these proteins exhibited exactly the same functional ability although their amino acid compositions differed considerably except for that in the bHLH-motif region. In the present study, we obtained results suggesting that the same enhancer also regulated the transcription of these two genes at least during the early gastrulation stage. EME, which was identified by transient transgenic analysis, appeared to be used by both genes. This speculation was based on the result of the DE1-knockout embryo that exhibited a phenotype similar to that of the Mesp1, Mesp2-double-knockout mouse. In addition, we previously showed that b-gal activity in the homozygous Mesp1-LacZ embryo was not rapidly downregulated, and strong activity was continuously observed in the gastrulating embryo at the later stage of development (Saga et al., 1999) . This indicates that Mesp1 expression is regulated by a negative feedback by Mesp1 itself. This may be the cause of the prolonged Mesp2 expression observed in the Mesp1-null embryo , and also indicates that the two genes are regulated by a common enhancer. However, further confirmation is necessary by analyzing an enhancer specific knockout mouse; this will be left for future study.
Transcriptional regulation of Mesp1
The endogenous expression of Mesp1 is clearly separated into two phases. One phase is observed in the early nascent mesoderm that differentiates into extraembryonic, cranial, and cardiac mesoderms (Saga et al., 1999) , and this expression is rapidly downregulated before somitogenesis; the other phase is observed in the anterior part of the presomitic mesoderm during somitogenesis. Although the minimum fragment, P1L-NB, exhibits an enhancer activity for both the early and presomitic mesoderms, the expression profile directed by the enhancer is different from that of the endogenous one. The initial expression of the P1L transgene was similar to that of the endogenous one, but the area was expanded, because the lateral plate mesoderm, in which endogenous Mesp1 was never activated, was b-gal-positive. Similarly, the initial expression observed in the presomitic mesoderm resembled that of the endogenous one. However, it was retained after segmentation although the level of expression became low. Furthermore, it was reactivated at the later stage in the myogenic cell lineage. Therefore, the enhancer may contain the elements required for the initiation of transcription at the right place in either early or presomitic mesoderm, but it may lack other regulatory elements required for the restriction of the transcription at the right time. Further study is required to elucidate the developmental regulation in the context of genomic organization.
Complex regulation of Mesp2
One of the notable findings in this study is the separation of the Mesp2 enhancer into at least two elements: one for the transcriptional activation in both prospective rostral and caudal compartments of somites and the other, for the suppression of such activity in the prospective caudal compartment. A previous study using in vitro cultivation of the presomitic mesoderm revealed that the Mesp2 expression domain was differentially regulated between the prospective rostral and caudal compartments. During cultivation, only the transcription in the caudal half was rapidly downregulated, leaving that in the rostral half intact (Takahashi et al., 2000) . This is the most important mechanism for the establishment of rostral and caudal somite compartments during somitogenesis. In this study, the TTTCCCAG sequence that is shared by mouse and zebrafish Mesp genes, is identified as a candidate for one of the transcriptional activators. However, we have not succeeded in reproducing the activity using the minimum promoter element (data not shown). In addition, existence of another upstream sequence(s) is implicated by the transgene analysis. For the suppression pathway, Notch signaling is implicated because the suppression of the Mesp2 expression in the caudal half is not observed in the Presenilin-1-knockout mouse (Koizumi et al., 2001 ). The cis-sequence involved in this suppression remains to be identified. Another notable cis-element suggested in this study is the temporal suppressor in the tailbud region. PSM cells originating in the tailbud region must be immature for the Mesp2 transcription. However, P2L-160 and P2L-158, which contain a core sequence, prematurely activate transgene in the tailbud region. Therefore, we speculate that some cis-sequences are involved in the suppression when PSM cells are in the tailbud region. Therefore, more detail dissection of the enhancer region is required for the precise understanding of the regulatory network. The identification of the upstream factors responsible for Mesp2 regulation is critical in determining genetic cascades involved in the initiation of segmentation in vertebrates.
Experimental procedures
Construction of transgenes
Genomic clones for mouse Mesp1 and Mesp2 were isolated by screening a genomic library established in l FixII of TT2 ES cell DNA using an Mesp1 cDNA probe. For the P1L construct, a 5 0 upstream DNA fragment spanning from the HindIII site to the NcoI site in the translation initiation site of Mesp1 was ligated to the NcoI site of LacZ.
A series of deletion constructs were generated using appropriate restriction enzymes and are shown in Fig. 1 . For a series of P1L-NB constructs, various DNA fragments that were prepared by digestion using appropriate restriction enzymes were ligated into the P1L-B2 construct that had only the promoter activity and no enhancer activity. For the P2L constructs, a 5 0 upstream DNA fragment spanning from the EcoRI site to the NcoI site in the translation initiation site of Mesp2 was ligated to the NcoI site of LacZ. To generate deletion clones, appropriate restriction enzyme sites were used to yield a P2L-B or P2L-P construct, and other constructs containing shorter DNA fragments were generated by PCR using specific primers for the 5 0 sequence of Mesp2 and LacZ. LacZ is derived from pactbgal (Maekawa et al., 1991) and the polyadenylation signal sequence is derived from that of the simian virus 40.
Transient transgenic analysis
Transgenic mice were generated by pronuclear injection of LacZ constructs (3 ng/ml) into fertilized eggs obtained from intercrosses between (C57BL/6xC3H) F1 mice (Hogan et al., 1994) . The embryos injected with LacZ constructs were transferred into pseudopregnant recipients, and allowed to develop in utero until analysis. The recovered embryos were analyzed for b-galactosidase (b-gal) expression by staining, and subsequently examined for the presence of the transgene by PCR analysis. The method for detecting b-gal activity was described previously (Saga et al., 1992) . Primers used to amplify the LacZ sequence were 5 0 -TTGCCGTCTGAATTTGACCTG-3 0 and 5 0 -TCTGCT-TCAATCAGCGTGCC-3 0 (Sasaki and Hogan, 1996) .
Permanent transgenic lines
For some LacZ constructs, the transgenic embryos were allowed to develop to term, and permanent transgenic lines were established. The presence of the transgene was examined by PCR analysis.
Targeting strategy for DE1
To construct a targeting vector, a 6-kb 5 0 upstream DNA fragment spanning from the EcoRI site to the BamHI site of Mesp2 was used as the long homology arm. For the short homology arm, a 1.3-kb XbaI fragment spanning from exon 2 of Mesp1 to the downstream genomic region was used. These fragments were ligated with pgk-neo and DT-A cassettes to construct the targeting vectors TV-DE1. The vector was linearized and introduced into TT2 ES cells [C57BL/6(B6)/CBA] by electroporation as described previously (Yagi et al., 1993) . After selection with G418, resistant clones were isolated and their DNAs were analyzed by PCR using a neo specific primer, NeoAL, and a Mesp1 genomic primer, GR1. The sequences for these primers were: NeoAL, 5 0 -GAAAGAACCAGCTGGGGCTCGAG-3 0 and Mesp1-GR1, 5 0 -ATATGCCAAGTCATTGAGGT-GAGCTTTC-3 0 .
Embryo manipulations and aggregation of the ES cell clones with ICR 8-cell embryos were carried out as described previously . Chimeric mice with high contribution of the TT2 genetic background (monitored by agouti coat color) were bred with ICR mice.
